Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Clear Cell Renal Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT06783348
What this trial is testing

Radiopharmaceutical Treatment of Advanced Kidney Cancer

Who this might be right for
Metastatic Clear Cell Renal Cell Carcinoma
European Organisation for Research and Treatment of Cancer - EORTC 48
Testing effectiveness (Phase 2)UnknownNCT05567588
What this trial is testing

Pembrolizumab Plus Radiotherapy for Advanced Renal Cancer

Who this might be right for
Clear-cell Metastatic Renal Cell Carcinoma
Nanfang Hospital, Southern Medical University 66
Testing effectiveness (Phase 2)Study completedNCT01408004
What this trial is testing

Rotating Pazopanib and Everolimus to Avoid Resistance

Who this might be right for
Clear Cell Renal Carcinoma
Netherlands Working Group on Immunotherapy of Oncology 101
Testing effectiveness (Phase 2)Ended earlyNCT02089334
What this trial is testing

Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer

Who this might be right for
Metastatic Renal Cell Cancer
Rexahn Pharmaceuticals, Inc. 24
Not applicableUnknownNCT01295463
What this trial is testing

Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

Who this might be right for
Cancer
Institut Català d'Oncologia 96
Testing effectiveness (Phase 2)Active Not RecruitingNCT01038778
What this trial is testing

Entinostat in Combination With Aldesleukin in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 47
Testing effectiveness (Phase 2)Ended earlyNCT04300140
What this trial is testing

Safety and Efficacy Study of AVB-S6-500 (Batiraxcept) in Patients With Advanced or Metastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Clear Cell Renal Cell Carcinoma
Aravive, Inc. 72
Early research (Phase 1)Ended earlyNCT02837991
What this trial is testing

A Dose Escalation, Safety and Activity Study of CDX-014 in Patients With Renal Cell Carcinoma and Ovarian Clear Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma (RCC)Clear-cell Renal Cell CarcinomaPapillary Renal Cell Carcinoma+3 more
Celldex Therapeutics 16
Testing effectiveness (Phase 2)Study completedNCT01034878
What this trial is testing

Sunitinib in Metastatic Renal Cancer

Who this might be right for
Carcinoma, Renal Cell
Istituto Clinico Humanitas 25
Testing effectiveness (Phase 2)Study completedNCT01524926
What this trial is testing

CREATE: Cross-tumoral Phase 2 With Crizotinib

Who this might be right for
Locally Advanced and/or Metastatic Anaplastic Large Cell LymphomaLocally Advanced and/or Metastatic Inflammatory Myofibroblastic TumorLocally Advanced and/or Metastatic Papillary Renal Cell Carcinoma Type 1+3 more
European Organisation for Research and Treatment of Cancer - EORTC 582
Early research (Phase 1)Ended earlyNCT00623077
What this trial is testing

MT2004-30: Tomotherapy for Solid Tumors

Who this might be right for
Brain and Central Nervous System TumorsKidney CancerLiver Cancer+2 more
Masonic Cancer Center, University of Minnesota 23
Testing effectiveness (Phase 2)Study completedNCT01835158
What this trial is testing

Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Kidney CarcinomaStage III Renal Cell Cancer AJCC v7+1 more
National Cancer Institute (NCI) 157
Testing effectiveness (Phase 2)Study completedNCT02978404
What this trial is testing

Combining Radiosurgery and Nivolumab in the Treatment of Brain Metastases

Who this might be right for
Clear-Cell Metastatic Renal Cell CarcinomaNon Small Cell Lung Cancer MetastaticBrain Metastases, Adult+2 more
Centre hospitalier de l'Université de Montréal (CHUM) 26
Testing effectiveness (Phase 2)Active Not RecruitingNCT03092856
What this trial is testing

Axitinib With or Without Anti-OX40 Antibody PF-04518600 in Treating Patients With Metastatic Kidney Cancer

Who this might be right for
Clear Cell Renal Cell CarcinomaMetastatic Renal Cell CancerRecurrent Renal Cell Carcinoma+1 more
University of Southern California 62
Early research (Phase 1)Study completedNCT01061411
What this trial is testing

Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Clear Cell Sarcoma of the KidneyRecurrent Renal Cell CarcinomaStage III Renal Cell Cancer+1 more
Roswell Park Cancer Institute 16
Not applicableLooking for participantsNCT05753839
What this trial is testing

The Role of Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma in Immuno-oncology Era: SEVURO-CN Trial

Who this might be right for
Kidney CancerClear Cell Renal Cell Carcinoma MetastaticSynchronous Neoplasm
Yonsei University 40
Testing effectiveness (Phase 2)UnknownNCT03592199
What this trial is testing

Biomarker Study of Pts With Metastatic ccRCC Undergoing Sequential Therapy With 1st Line Sunitinib and 2nd Line Axitinib

Who this might be right for
Clear Cell Renal Cell Carcinoma
Instituto do Cancer do Estado de São Paulo 7
Testing effectiveness (Phase 2)Study completedNCT04118855
What this trial is testing

Toripalimab Combined With Axitinib as Neoadjuvant Therapy in Patients With Non-metastatic Locally Advanced Nonmetastatic Clear Cell Renal Cell Carcinoma

Who this might be right for
Neoadjuvant Therapy of Non-metastatic Locally Advanced Renal Cell Carcinoma
RenJi Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00979966
What this trial is testing

Study in Non-Clear Cell Renal Carcinoma (Ncc-RCC) Temsirolimus Versus Sunitinib

Who this might be right for
Non-clear Cell Renal Cell Cancer
Central European Society for Anticancer Drug Research 22
Testing effectiveness (Phase 2)Looking for participantsNCT06683846
What this trial is testing

Ivonescimab in the Treatment of Multiple Advanced Tumors

Who this might be right for
Pheochromocytoma/ParagangliomaRhabdomyosarcomaPaget Disease, Extramammary+16 more
Fudan University 400
Next Page